Gnaphalium Polycephalum is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Pseudognaphalium Obtusifolium.
| Product ID | 37662-0929_e3dd4ac1-429f-723b-e053-2a95a90a892d |
| NDC | 37662-0929 |
| Product Type | Human Otc Drug |
| Proprietary Name | Gnaphalium Polycephalum |
| Generic Name | Gnaphalium Polycephalum |
| Dosage Form | Pellet |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-07-15 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / |
| Labeler Name | Hahnemann Laboratories, INC. |
| Substance Name | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| Active Ingredient Strength | 12 [hp_C]/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-07-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0220-2306 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 0220-2307 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 0220-2310 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 0220-2313 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 15631-0208 | GNAPHALIUM POLYCEPHALUM | GNAPHALIUM POLYCEPHALUM |
| 15631-0592 | GNAPHALIUM POLYCEPHALUM | GNAPHALIUM POLYCEPHALUM |
| 37662-0928 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0929 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0930 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0931 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0932 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0933 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 37662-0934 | Gnaphalium Polycephalum | Gnaphalium Polycephalum |
| 68428-409 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |
| 71919-321 | Gnaphalium polycephalum | PSEUDOGNAPHALIUM OBTUSIFOLIUM |